Development of immunity against hepatitis B virus after donor lymphocyte infusion in a peripheral blood stem cell transplantation recipient with chronic hepatitis B

Infection

Volumn 39, Issue 4, 2011, Pages 363-365

  Chiang, L T ^a   Yao, M ^a   Ko, B S ^a   Chen, C H ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Donor lymphocyte infusion; Hepatitis B; Stem cell transplantation

Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; THYMOCYTE ANTIBODY; VIRUS DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ADAPTIVE IMMUNITY; ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ANTIBODY BLOOD LEVEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER REGRESSION; CANCER RESISTANCE; CASE REPORT; CD3+ T LYMPHOCYTE; DISEASE EXACERBATION; DONOR LYMPHOCYTE INFUSION; ENZYME BLOOD LEVEL; ENZYME IMMUNOASSAY; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIMIT OF DETECTION; MALE; PANCYTOPENIA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; REAL TIME POLYMERASE CHAIN REACTION; SEROCONVERSION; VIRUS IMMUNITY; VIRUS LOAD;

ADENINE; ADOPTIVE TRANSFER; ANTIVIRAL AGENTS; DNA, VIRAL; DRUG COMBINATIONS; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; LEUKEMIA, MYELOID, ACUTE; LYMPHOCYTE TRANSFUSION; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHOSPHONIC ACIDS; TAIWAN; TREATMENT OUTCOME; UNRELATED DONORS;

EID: 80655149172     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-011-0120-x     Document Type: Article

References (16)

1. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis. 2002;2:395-403.
2. Lok AS, Mc Mahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50:661-2.
3. Ilan Y, Nagler A, Adler R, Naparstek E, Or R, Slavin S, Brautbar C, Shouval D. Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation. Hepatology. 1993;18:246-52. (Pubitemid 23225091)
4. Lindemann M, Barsegian V, Runde V, Fiedler M, Heermann KH, Schaefer UW, Roggendorf M, Grosse-Wilde H. Transfer of humoral and cellular hepatitis B immunity by allogeneic hema-topoietic cell transplantation. Transplantation. 2003;75:833-8. (Pubitemid 36373457)
5. Lau GK, Lok AS, Liang RH, Lai CL, Chiu EK, Lau YL, Lam SK. Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer. Hepatology. 1997;25:1497-501. (Pubitemid 27250775)
6. Ilan Y, Nagler A, Adler R, Tur-Kaspa R, Slavin S, Shouval D. Ablation ofpersistent hepatitis B by bone marrow transplantation from ahepatitis B-immune donor. Gastroenterology. 1993;104:1818-21. (Pubitemid 23235477)
7. Lau GK, Liang R, Lee CK, Lim WL. Is vaccination of donor adequate for clearance of hepatitis B virus after bone-marrow transplantation? Lancet. 1997;349:1626-7. (Pubitemid 27229156)
8. Lau GK, Liang R, Lee CK, Yuen ST, Hou J, Lim WL, Williams R. Clearance of persistent hepatitis B virus infection in Chinese bone marrow transplant recipients whose donors were anti-hep-atitis B core- and anti-hepatitis B surface antibody-positive. J Infect Dis. 1998;178:1585-91. (Pubitemid 28558127)
9. Lau GK, Suri D, Liang R, Rigopoulou EI, Thomas MG, Mul-lerova I, Nanji A, Yuen ST, Williams R, Naoumov NV. Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterology. 2002;122:614-24. (Pubitemid 34173812)
10. Ilan Y, Nagler A, Shouval D, Ackerstein A, Or R, Kapelushnik J, Adler R, Slavin S. Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donors. Clin Exp Immunol. 1994;97:299-302. (Pubitemid 24263074)
11. Shouval D, Adler R, Ilan Y. Adoptive transfer of immunity to hepatitis B virus in mice by bone marrow transplantation from immune donors. Hepatology. 1993;17:955-9. (Pubitemid 23187395)
12. Kaloyannidis P, Batsis I, Yannaki E, Adamidou D, Bartzoudis D, Papathanasiou M, Mallouri D, Sakellari I, Fassas A, Anagnos-topoulos A. Allografted recipients immunized against hepatitis B virus are at high risk of gradual surface antibody (Hbs Ab) dis-appearance post transplant, regardless of adoptive immunity transfer. Biol Blood Marrow Transplant. 2007;13:1049-56. (Pubitemid 47215561)
13. Liaw YF, Lau GK, Kao JH, Gane E. Hepatitis Beantigen seroconversion: a critical event in chronic hepatitis B virus infection. Dig Dis Sci. 2010;55:2727-34.
14. Liaw YF, Leung N, Kao JH, Piratvisuth T, Gane E, Han KH, Guan R, Lau GK, Locarnini S. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hep-atol Int. 2008;2:263-83.
15. Chiba T, Yokosuka O, Goto S, Fukai K, Imazeki F, Shishido H, Narita M, Saisho H. Successful clearance of hepatitis B virus after allogeneic stem cell transplantation: beneficial combination of adoptive immunity transfer and lamivudine. Eur J Haematol. 2003;71:220-3. (Pubitemid 37082847)
16. Hui CK, Lie A, Au WY, Leung YH, Ma SY, Cheung WW, Zhang HY, Chim CS, Kwong YL, Liang R, Lau GK. A long-term fol-low-up study on hepatitis B surface antigen-positive patients undergoing allogeneic hematopoietic stem cell transplantation. Blood. 2005;106:464-9. (Pubitemid 40981239)